| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Greenwich Lifesciences, Inc. (GLSI) has 1 insider with recent SEC Form 4 filings, including 12 buys and 0 sells. GLSI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.61M | $80.75M | +7.3K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Patel Snehal61 | CEO And CFO | Buy | 2,200 | $13.43 | $29,555.00 | - | - | - | |
| Jul 27, 2026 | Patel Snehal61 | CEO And CFO | Buy | 1,500 | $13.62 | $20,430.00 | - | - | - | |
| Jul 24, 2026 | Patel Snehal61 | CEO And CFO | Buy | 3,600 | $13.06 | $47,018.00 | - | - | - | |
| Jan 13, 2026 | Patel Snehal61 | CEO And CFO | Buy | 1,800 | $29.83 | $53,694.00 | - | -11.2% | - | |
| Jan 12, 2026 | Patel Snehal61 | CEO And CFO | Buy | 2,900 | $27.54 | $79,866.00 | - | -3.9% | - | |
| Dec 31, 2025 | Patel Snehal61 | CEO And CFO | Buy | 4,300 | $21.36 | $91,848.00 | - | +14.3% | - | |
| Dec 30, 2025 | Patel Snehal61 | CEO And CFO | Buy | 2,900 | $21.73 | $63,017.00 | - | -2.0% | - | |
| Dec 18, 2025 | Patel Snehal61 | CEO And CFO | Buy | 4,100 | $12.62 | $51,742.00 | - | +115.6% | - | |
| Nov 25, 2025 | Patel Snehal61 | CEO And CFO | Buy | 4,600 | $8.37 | $38,502.00 | - | +170.2% | - | |
| Nov 7, 2025 | Patel Snehal61 | CEO And CFO | Buy | 10,600 | $8.43 | $89,358.00 | +0.2% | +190.9% | - |